279 related articles for article (PubMed ID: 10086334)
1. Overexpression of D-type cyclins, E2F-1, SV40 large T antigen and HPV16 E7 rescue cell cycle arrest of tsBN462 cells caused by the CCG1/TAF(II)250 mutation.
Sekiguchi T; Nishimoto T; Hunter T
Oncogene; 1999 Mar; 18(10):1797-806. PubMed ID: 10086334
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of transcription of p21 and cyclin D1 conferred by TAF(II)250.
Rushton JJ; Steinman RA; Robbins PD
Cell Growth Differ; 1997 Oct; 8(10):1099-104. PubMed ID: 9342188
[TBL] [Abstract][Full Text] [Related]
3. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription.
Adnane J; Shao Z; Robbins PD
Oncogene; 1999 Jan; 18(1):239-47. PubMed ID: 9926939
[TBL] [Abstract][Full Text] [Related]
5. The ts13 mutation in the TAF(II)250 subunit (CCG1) of TFIID directly affects transcription of D-type cyclin genes in cells arrested in G1 at the nonpermissive temperature.
Suzuki-Yagawa Y; Guermah M; Roeder RG
Mol Cell Biol; 1997 Jun; 17(6):3284-94. PubMed ID: 9154827
[TBL] [Abstract][Full Text] [Related]
6. D-type cyclin expression is decreased and p21 and p27 CDK inhibitor expression is increased when tsBN462 CCG1/TAFII250 mutant cells arrest in G1 at the restrictive temperature.
Sekiguchi T; Noguchi E; Hayashida T; Nakashima T; Toyoshima H; Nishimoto T; Hunter T
Genes Cells; 1996 Jul; 1(7):687-705. PubMed ID: 9078394
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor.
Sekiguchi T; Nakashima T; Hayashida T; Kuraoka A; Hashimoto S; Tsuchida N; Shibata Y; Hunter T; Nishimoto T
Exp Cell Res; 1995 Jun; 218(2):490-8. PubMed ID: 7796884
[TBL] [Abstract][Full Text] [Related]
8. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
9. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
10. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
11. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
Kastner A; Espanel X; Brun G
Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
[TBL] [Abstract][Full Text] [Related]
13. CCG1/TAF(II)250 regulates epidermal growth factor receptor gene transcription in cell cycle mutant ts13.
Vargas GA; Isas JM; Fantino E; Gargus JJ; Haigler HT
J Cell Physiol; 1998 Sep; 176(3):642-7. PubMed ID: 9699517
[TBL] [Abstract][Full Text] [Related]
14. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.
Schulze A; Zerfass K; Spitkovsky D; Henglein B; Jansen-Dürr P
Oncogene; 1994 Dec; 9(12):3475-82. PubMed ID: 7970707
[TBL] [Abstract][Full Text] [Related]
15. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.
Hiyama H; Iavarone A; LaBaer J; Reeves SA
Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053
[TBL] [Abstract][Full Text] [Related]
16. Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.
Dunphy EL; Johnson T; Auerbach SS; Wang EH
Mol Cell Biol; 2000 Feb; 20(4):1134-9. PubMed ID: 10648598
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
18. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110.
Mazzarelli JM; Atkins GB; Geisberg JV; Ricciardi RP
Oncogene; 1995 Nov; 11(9):1859-64. PubMed ID: 7478615
[TBL] [Abstract][Full Text] [Related]
19. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
[TBL] [Abstract][Full Text] [Related]
20. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
